In COPD patients, the Th17/Treg cell balance shifts toward Th17 cells, which triggers inflammatory responses in the airways and lungs and exacerbates alveolar destruction by producing interleukin-17 (IL-17) (Brusselle et al., 2011; Eppert et al., 2013). The gene discussed is IL17A; the disease is chronic obstructive pulmonary disease.